ArticleCancers2026

Association Between Patient-Reported Outcomes and Overall Survival in Patients with Advanced NSCLC Treated with First-Line Cemiplimab-Based Therapy.

David R Gandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.